Featured Post

Latest Gold News

Weak dollar, equities supporting gold Trump remains unimpressed with NAFTA   Business cycle winding down says Wall Street banks Klon...

Wednesday, January 11, 2012

DSW (DSW) (REGN) (RMTI) (RSTI) (DBLE) (DEI) Upgraded

DSW (NYSE: DSW), Regeneron Pharma (NASDAQ: REGN), Rockwell Medical (NASDAQ: RMTI), Rofin-Sinar Technologies (NASDAQ: RSTI), Double Eagle Petroleum (NASDAQ: DBLE) and Douglas Emmett (NYSE: DEI) were upgraded by analysts.

Regeneron Pharma (REGN) was upgraded by Robert W. Baird from a “Neutral” rating to an “Outperform” rating. They have a price target of $81.00 on the company, up from $56.00.

Rockwell Medical (RMTI) was upgraded by Zacks Investment Research from an “Underperform” rating to a “Neutral” rating.

Rofin-Sinar Technologies (RSTI) was upgraded by Zacks Investment Research from an “Underperform” rating to a “Neutral” rating.

Double Eagle Petroleum (DBLE) was upgraded by Zacks Investment Research from an “Underperform” rating to a “Neutral” rating.

Douglas Emmett (DEI) was upgraded by Raymond James (NYSE:RJF) from a “Market Perform” rating to an “Outperform” rating.

DSW (DSW) was upgraded by Zacks Investment Research from a “Neutral” rating to an “Outperform” rating.

No comments: